Table: RaQualia Pharma -Q1 group results

RaQualia Pharma

13/05/2022 07:15

May 13 (Reuters)- 
             RaQualia Pharma Inc 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                   3 months ended      3 months ended       Year to 
                  Mar 31, 2022        Mar 31, 2021     Dec 31, 2022 
                     LATEST             YEAR-AGO          LATEST    
                     RESULTS             RESULTS         FORECAST   
  Sales              339 mln             655 mln           2.61     
                   (-48.3 pct)        (+430.7 pct)      (-6.2 pct)  
  Operating       loss 119 mln           149 mln          420 mln   
                                                        (-40.6 pct) 
  Recurring        loss 70 mln           268 mln          420 mln   
                                                        (-51.3 pct) 
  Net             loss 120 mln           188 mln          342 mln   
                                                        (-54.7 pct) 
  EPS             loss 5.77 yen         9.00 yen         16.34 yen  
  EPS Diluted                           9.00 yen                    
  Ann Div                                  NIL              NIL     
  -Q2 div                                  NIL              NIL     
  -Q4 div                                  NIL              NIL     
  
  NOTE - RaQualia Pharma Inc. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4579.T